Correlation Between Okta and Jasper Therapeutics
Can any of the company-specific risk be diversified away by investing in both Okta and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Jasper Therapeutics, you can compare the effects of market volatilities on Okta and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Jasper Therapeutics.
Diversification Opportunities for Okta and Jasper Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Okta and Jasper is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of Okta i.e., Okta and Jasper Therapeutics go up and down completely randomly.
Pair Corralation between Okta and Jasper Therapeutics
Given the investment horizon of 90 days Okta Inc is expected to generate 0.25 times more return on investment than Jasper Therapeutics. However, Okta Inc is 4.02 times less risky than Jasper Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Jasper Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 7,189 in Okta Inc on September 1, 2024 and sell it today you would earn a total of 567.00 from holding Okta Inc or generate 7.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 80.95% |
| Values | Daily Returns |
Okta Inc vs. Jasper Therapeutics
Performance |
| Timeline |
| Okta Inc |
| Jasper Therapeutics |
Okta and Jasper Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Jasper Therapeutics
The main advantage of trading using opposite Okta and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.The idea behind Okta Inc and Jasper Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Jasper Therapeutics vs. SAB Biotherapeutics | Jasper Therapeutics vs. NRx Pharmaceuticals | Jasper Therapeutics vs. Celularity |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |